ESG

The Non-GMO Project's grant program helps BIPOC food entrepreneurs overcome barriers, gain market access, and reshape the natural products industry.

With backing from a top hospital, VolitionRx seeks reimbursement for its Nu.Q® blood test, aiming to transform lung cancer care in France and beyond.

Sustainable energy leader VivoPower is betting its future on the power-hungry AI industry. Can it build a data center empire and still stay green?

Critical Metals Corp secures a key 2-year license for its Austrian lithium project, positioning it to capitalize on soaring prices and EU supply goals.

Incheon National University develops a high-performance, eco-friendly gas sensor that dissolves in seawater, tackling both e-waste and air quality issues.

An Austin-based tech company's platform, which integrates into doctors' workflows, has cut prescription costs for nearly 60,000 Ohio residents.

Orlando's SunDance adds a third production facility, leveraging advanced printing tech to meet soaring demand for sustainable packaging and commercial printing.

Activity Connection and Zinnia TV unite to offer an integrated solution, easing staff burnout and enhancing person-centered care for older adults.

IperionX's Virginia facility is now fully operational, backed by major DoD funding to reshape the US titanium and critical minerals supply chain.

ALX Oncology data shows CD47 levels predict response to evorpacept, offering new hope for heavily pretreated patients in a crowded therapeutic landscape.

Ruxolitinib cream's landmark approval in China marks a new era for vitiligo treatment, impacting patients, markets, and regulatory policy.

The 140-year-old industrial giant earns a coveted spot on Fortune's list, recognized for its innovation in smart buildings and sustainability leadership.

A major real-world study shows physician-led medical cannabis use improves pain, anxiety, and quality of life, adding key evidence to the field.

CIRM's new RAPID program aims to revolutionize genetic therapy, using scalable platforms to bring hope to millions with rare diseases who have no options.

Facing a cash crunch after a major clinical trial setback, the cancer vaccine developer is exploring a sale or merger, putting its pipeline at risk.

TotalEnergies and Galp deepen their partnership in the Orange Basin, meeting with Namibia's President to fast-track the nation's rise as a new energy hub.

A $10M investment from pharma giant Dr. Reddy’s validates Coya Therapeutics' novel ALS drug, funding the path to commercial-scale manufacturing.

The Cardinal Newman Society has honored Divine Mercy University for its unique integration of professional psychology with a faithful Catholic worldview.

The market for drugs like Ozempic and Wegovy is set to explode, fueled by new oral pills, expanded uses for heart and liver disease, and fierce competition.

Tonix Pharmaceuticals' newly approved drug, TONMYA, offers a breakthrough for millions, using unique science to combat the chronic pain of fibromyalgia.